Gilde IT Fund
Gilde IT Fund is a private equity firm that is interested in early-stage and late-stage venture opportunities
All edits
Gilde IT Fund is a private equity firm that is interested in early-stage and late-stage venture opportunities. The firm was founded in 1982 in Utrecth, Utrecth, The Netherlands.
The firm is interested in providing for offices in the Netherlands, France, Switzerland, and with other prominent continental European private equity investors. The firm is specialized in investment funds for buy outs and life sciences, and manages funds that exceed $2 billion. The firm has made a total of twenty-two investments in companies such as SPR Therapeutics, NeoProteomics, and Chroma Therapeutics.
The firm is interested in providing for offices in the Netherlands, France, Switzerland, and with other prominent continental European private equity investors. The firm is specialized in investment funds for buy outs and life sciences, and manages funds that exceed $2 billion. The firm has made a total of twenty-two investments in companies such as SPR Therapeutics, NeoProteomicsNeoProteomics, and Chroma Therapeutics.
The firm is interested in providing for offices in the Netherlands, FranceFrance, Switzerland, and with other prominent continental European private equity investors. The firm is specialized in investment funds for buy outs and life sciences, and manages funds that exceed $2 billion. The firm has made a total of twenty-two investments in companies such as SPR Therapeutics, NeoProteomics, and Chroma Therapeutics.
The firm is interested in providing for offices in the Netherlands, France, Switzerland, and with other prominent continental European private equity investors. The firm is specialized in investment funds for buy outs and life sciences, and manages funds that exceed $2 billion. The firm has made a total of twenty-two investments in companies such as SPR TherapeuticsSPR Therapeutics, NeoProteomics, and Chroma Therapeutics.
The firm is interested in providing for offices in the Netherlands, France, SwitzerlandSwitzerland, and with other prominent continental European private equity investors. The firm is specialized in investment funds for buy outs and life sciences, and manages funds that exceed $2 billion. The firm has made a total of twenty-two investments in companies such as SPR Therapeutics, NeoProteomics, and Chroma Therapeutics.
The firm is interested in providing for offices in the NetherlandsNetherlands, France, Switzerland, and with other prominent continental European private equity investors. The firm is specialized in investment funds for buy outs and life sciences, and manages funds that exceed $2 billion. The firm has made a total of twenty-two investments in companies such as SPR Therapeutics, NeoProteomics, and Chroma Therapeutics.
Gilde IT Fund is a private equity firmprivate equity firm that is interested in early-stage and late-stage venture opportunities. The firm was founded in 1982 in Utrecth, Utrecth, The Netherlands.
Gilde IT Fund
Gilde IT Fund is a private equity firm that is interested in early-stage and late-stage venture opportunities
Gilde IT Fund is a private equity firm that is interested in early-stage and late-stage venture opportunities. The firm was founded in 1982 in Utrecth, Utrecth, The Netherlands.
The firm is interested in providing for offices in the Netherlands, France, Switzerland, and with other prominent continental European private equity investors. The firm is specialized in investment funds for buy outs and life sciences, and manages funds that exceed $2 billion. The firm has made a total of twenty-two investments in companies such as SPR Therapeutics, NeoProteomics, and Chroma Therapeutics.
Find more companies like Gilde IT Fund
